Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
RINZ (RUSSIA)
|
Регистрационное агентство DOI (США)
DOI Registration Agency (USA)
|
Эко-Вектор (Россия)
Eco-Vector (Russia)
|
Ulrichsweb (Ulrich’s Periodicals Director
|
HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NEPHROPATHY
DOI: https://doi.org/10.29296/25879979-2019-07-09
Issue:
7
Year:
2019
The paper considers modern ideas about human immunodeficiency virus-associated nephropathy. It discloses the features of pathogenesis and clinical manifestations and the subtleties of diagnosis and treatment of this pathology.
Keywords:
human immunodeficiency virus
AIDS
nephropathy
kidney biopsy
renal failure
References:
- Dannye Rosstata po zabolevaemosti VICh. https: http://www.gks.ru/free_doc/doc_2018/social/osn-04-2018.pdf
- VICh-infektsija. Informatsionnyj bjulleten' Federal'nogo nauchno-metodicheskogo tsentra po profilaktike i bor'be so SPIDom Tsentral'nogo NII epidemiologii. Moskva.
- Volgina G.V., Gadzhikulieva M.M. Natsional'nye klinicheskie rekomendatsii. Hronicheskaja bolezn' pochek u VICh-infitsirovannyh patsientov. M., 2015; 34.
- Natsional'nye klinicheskie rekomendatsii po dispansernomu nabljudeniju i lecheniju bol'nyh VICh-infektsiej. Klinicheskij protokol. 2016; 72.
- Rekomendatsii Evropejskogo klinicheskogo obschestva SPIDa, versija 9,0. 2017; 104.
- VICh-infektsija i SPID: klinicheskie rekomendatsii. Pod red. V.V. Pokrovskogo. 3-e izd., pererab. i dop. M.: GOETAR-Media, 2016; 112.
- Juschuk N., Gadzhikulieva M., Volgina G., Tomilina N. Glomeruljarnye zabolevanija u VICh-infitsirovannyh patsientov: klinicheskaja i morfologicheskaja otsenka. Terapevt arhiv. 2012; 11: 30–3.
- Libman G., Makadon H. Dzh. VICh-infektsii. Per. s angl.; pod red. A.I. Mazusa, T.P. Bessaraba. M.: GEOTAR-Media, 2012; 560.
- Zhuravleva M.S., Skvortsov V.V. Printsipy diagnostiki i lechenija VICh-infektsii. Meditsinskaja sestra. 2016; 7: 14–21.
- Burns G., Paul S., Toth I. et al. Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. J. Am. Soc. Nephrol. 1997; 8: 1140–6.
- Cosgrove C., Abu–Alfa A., Perazella M. Observations on HIV-associated renal disease in the era of highly active antiretroviral therapy. Am. J. Med. Sci. 2002; 323 (2): 102–6.
- Ting–chi L., Ross M. HIV-associated nephropathy: a brief review. Mount Sinai J. Med. 2005; 75 (3): 193–9.
- United States Renal Data System 2003 annual data report: atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, 2003.
- Wei A., Burns G., Williams B. et al. Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition. Kidney Int. 2003; 64 (4): 1462–71.
- Winston J., Bruggeman L., Ross M. et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N. Engl. J. Med. 2001; 344 (26): 1979–84.
- Woolley I., Kalayjian R., Valdez H. et al. HIV nephropathy and the Duffy antigen. Receptor for Chemokines in African Americans. J. Nephrol. 2001; 14: 384–7.
- Transplantatsija pochki. Natsional'nye klinicheskie rekomendatsii. 2013; 50